Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
The said inspection concluded with Zero Form 483 observation
Subscribe To Our Newsletter & Stay Updated